pitolisant: Clinical Trials

5 trials of pitolisant, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 terminated. 5 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 15Completed 3, Terminated 2

Follow pitolisant: new trials by email Literature Review of pitolisant trials Research Report on pitolisant

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pitolisant Effects on Alcohol Self-Administration in Heavy Drinkers
Pitolisant, Placebo - Alcohol Use Disorder, Alcohol Drinking
Phase 1TerminatedBoston Medical Center92021-09-132023-12-04
Insulin Tolerance Test Study in Patients With Type 1 Diabetes
Pitolisant - Type 1 Diabetes, Hypoglycemia
Phase 1TerminatedHigh Point Clinical Trials Center52019-09-152021-04-02
Determination the Abuse Potential of Pitolisant in Healthy, Non-Dependent Recreational Stimulant Users
Pitolisant, Placebos, Phentermine - Healthy, Drug Abuse
Phase 1CompletedBioprojet432017-03-152017-11-13
Study to Assess the Absorption, Distribution, Metabolism and Excretion (ADME) of [14C]-Pitolisant in Healthy Male Volunteers
Pitolisant, [14C]-Pitolisant - Healthy Volunteers
Phase 1CompletedBioprojet82016-07-012016-10-11
Pharmacokinetics of BF2.649 in Renal Impairment
BF2.649 - Renal Impairment
Phase 1CompletedBioprojet252011-07-012013-04-12

Conditions studied

Alcohol Drinking (1)  ·  Alcoholism (1)  ·  Diabetes Mellitus, Type 1 (1)  ·  Hypoglycemia (1)  ·  Renal Insufficiency (1)  ·  Substance-Related Disorders (1)

Sponsors

Bioprojet (3)  ·  Boston Medical Center (1)  ·  High Point Clinical Trials Center (1)

Countries

United States (2)  ·  Canada (1)  ·  France (1)

Top investigators

Eric Devine, PhD (1)  ·  Litza McKenzie, MD (1)  ·  Melanie Fein, MD (1)  ·  Michael B. McDonnell, MD (1)  ·  Thierry Duvauchelle, MD (1)

Results publications

PMID 31626696

NIH funding

2016 (1), R21AA028864 (1)